Evaluation of platelet function and lack of response to epinephrine in pregnant women

International Journal of Laboratory Hematology

Volumn 29, Issue 4, 2007, Pages 302-309

  Sagdilek, E ^a   Buyukcoskun, N I ^a   Ozluk, K ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Aggregometer; Epinephrine; PFA 100; Platelets; Pregnancy

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRACELLULAR SPACE; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADULT; BLOOD PLATELETS; EPINEPHRINE; FEMALE; HUMANS; PLATELET AGGREGATION; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD;

EID: 34447249277     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2006.00844.x     Document Type: Article

References (39)

1. Avram S., Lupu A., Angelescu S., Olteanu N. Mut-Popescu D. (2001) Abnormalities of platelet aggregation in chronic myeloproliferative disorders. Journal of Cellular and Molecular Medicine 5, 79 87.
2. Brass L.F. (2003) Thrombin and platelet activation. Chest 124, 18 25.
3. Breddin H.K. (2005) Can platelet aggregometry be standardized Platelets 16, 151 158.
4. British Society for Haematology (2001) Guideline: investigation and management of heritable thrombophilia. British Journal of Haematology 114, 512 528.
5. Buyukasik Y., Karakus S., Goker H., Haznedaroglu İ.C., Ozatli D., Ozcebe O.İ., Dundar S.V. Kirazli S. (2002) Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coagulation and Fibrinolysis 13, 1 5.
6. Choi J.W. (2002) Incidence of nonresponsiveness to epinephrine in platelets from healthy humans. Acta Haematologica 108, 106 108.
7. Colman R.W., Hirsh J., Marder V.J., Clowes A.W. George J.N. (2001) Hemostasis and Thrombosis: Basic Priciples and Clinical Practice, 4th edn. J.B. Lippincott Company, Philadelphia, PA.
8. Dade Behring® (2000) To Aid in the Detection of Platelet Dysfunction in Citrated Human Whole Blood. Dade Behring, Marburg.
9. Eldor A. (2001) Thrombophilia, thrombosis and pregnancy. Thrombosis and Hemostasis 86, 104 111.
10. Favaloro E.J. (2001) Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations. Haemophilia 7, 170 179.
11. Harrison P., Robinson M.S.C., Mackie I.J., Joseph J., McDonald S.J., Liesner R., Savidge G.F., Pasi J. Machin S.J. (1999) Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis. Blood Coagulation and Fibrinolysis 10, 25 31.
12. Helena Laboratories (1991) PACKS-4® Operator's Manual. Helena Laboratories, Beaumont.
13. Jin J. Kunapuli S.P. (1998) Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proceedings of the National Academy of Sciences United States of America 95, 8070 8074.
14. Kambayashi J., Shinoki N., Nakamura T., Ariyoshi H., Kawasaki T., Sakon M. Monden M. (1996) Prevalence of impaired responsiveness to epinephrine in platelets among Japanese. Thrombosis Research 81, 85 90.
15. Kaywin P., McDonough M., Insel P.A. Shattil S.J. (1978) Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors. New England Journal of Medicine 299, 505 509.
16. Keularts I.M.L.W., van Gorp R.M.A., Feijge M.A.H., Vuist W.M.J. Heemskerk J.W.M. (2000) α2A-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. The Journal of Biological Chemistry 275, 1763 1772.
17. Maayani S., Schwarz T., Martinez R. Tagliente T.M. (2001) Activation of Gi-coupled receptors releases a tonic state of inhibited platelet agregation. Platelets 12, 94 98.
18. Mammen E., Comp P.C., Gosselin R., Greenberg C., Hoots W.K., Kessler C.M., Larkin E.C., Liles D. Nugent D.J. (1998) PFA-100TM System: a new method for assessment of platelet dysfunction. Thrombosis and Haemostasis 24, 195 202.
19. Martinelli I. (2001) Risk factors in venous thromboembolism. Thrombosis and Hemostasis 86, 395 403.
20. Nakahashi T.K., Kambayashi J., Nakamura T., Le S.N., Yoshitake M., Tandon N.N. Sun B. (2001) Platelets in nonresponders to epinephrine stimulation showed reduced response to ADP. Thrombosis Research 104, 127 135.
21. Nakamura T., Ariyoshi H., Kambayashi J., Ikeda M., Shinoki N., Kawasaki T. Monden M. (1997) Signal transduction system in epinephrine stimulated platelets; comparison between epinephrine sensitive and insensitive platelets. Thrombosis Research 85, 83 93.
22. Nieswandt B., Schulte V., Zywietz A., Gratacap M.P. Offermanns S. (2002) Costimulation of Gi- and G12/13-mediated signaling pathways induces integrin αIIbβ3 activation in platelets. The Journal of Biological Chemistry 277, 39493 39498.
23. Paul B.Z.S., Jin J. Kunapuli S.P. (1999) Molecular mechanism of thromboxane A2-induced platelet aggregation. The Journal of Biological Chemistry 274, 29108 29114.
24. Posan E., McBane R.D., Grill D.E., Motsko C.L. Nichols W.L. (2003) Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thrombosis and Haemostasis 90, 483 490.
25. Pyo M.K., Yun-Choi H.S. Hong Y.J. (2003) Apparent heterogeneous responsiveness of human platelet rich plasma to catecholamines. Platelets 14, 171 178.
26. Quinton T.M., Kim S., Dangelmaier C., Dorsam R.T., Jin J., Daniel J.L. Kunapuli S.P. (2002) Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation. Biochemical Journal 368, 535 543.
27. Sourav K.K., Eric J.H., Reynaldo S., Carmen G., Rosa M.D. Roy A.O. (2002) Description of an in vitro Platelet Function Analyzer - PFA-100. Thrombosis and Haemostasis 21, 106 112.
28. Storey R.F. Heptinstall S. (1999) Laboratory investigation of platelet function. Clinical and Laboratory Haematology 21, 317 329.
29. Swart S.S., Pearson D., Wood J.K. Barnett D.B. (1984) Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders. Thrombosis Research 33, 531 541.
30. Theodoropoulos I., Christopoulos C., Metcalfe P., Dimitriadou E., Economopoulos P. Loucopoulos D. (2001) The effect of human platelet alloantigen polymorphisms on the in vitro responsiveness to adrenaline and collagen. British Journal of Haematology 114, 387 393.
31. Wallaschofski H., Donné M., Eigenthaler M., Hentschel B., Faber R., Stepan H., Koksch M. Lohmann T. (2001) PRL as a novel potent cofactor for platelet aggregation. The Journal of Clinical Endocrinology & Metabolism 86, 5912 5919.
32. Wallaschofski H., Eigenthaler M., Kiefer M., Donné M., Hentschel B., Gertz H.J. Lohmann T. (2003a) Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study. Journal of Clinical Psychopharmacology 23, 479 483.
33. Wallaschofski H., Kobsar A., Koksch M., Siegemund A., Hentschel B., Tuschy U., Lohmann T., Sokolova O. Eigenthaler M. (2003b) Prolactin receptor signalling during platelet activation. Hormone and Metabolic Research 35, 228 235.
34. Wallaschofski H., Kobsar A., Sokolova O., Eigenthaler M. Lohmann T. (2004) Co-activation of platelets by prolactin or leptin - pathophysiological findings and clinical implications. Hormone and Metabolic Research 36, 1 6.
35. Walter A.W., Katharina M.G., Sacha S.Z. Bernhard L. (2002) Evaluation of a platelet function analyser (PFA-100) in patients with a bleeding tendency. Swiss Medical Weekly 132, 443 448.
36. Woulfe D., Yang J. Brass L. (2001) ADP and platelets: the end of the beginning. The Journal of Clinical Investigation 107, 1591 1598.
37. Yamamoto K., Sekiguchi E. Takatani O. (1984) Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders. Thrombosis and Haemostasis 52, 292 296.
38. Yang J., Wu J., Kowalska M.A., Dalvi A., Prevost N., O'Brien P.J., Manning D., Poncz M., Lucki I., Blendy J.A. Brass L.F. (2000) Loss of signalling through te G protein, Gz, results in abnormal platelet activation and altere responses to psychoactive drugs. Proceedings of the National Academy of Sciences United States of America 97, 9984 9989.
39. Yang J., Wu J., Jiang H., Mortensen R., Austin S., Manning D.R., Woulfe D. Brass L.F. (2001) Signaling through Gi family members in platelets. The Journal of Biological Chemistry 277, 46035 46042.